NCT03676231 Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH) Status TERMINATED Phase PHASE2
NCT03674476 An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function Status COMPLETED Phase PHASE1
NCT03656744 A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE2
NCT03486912 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis Status COMPLETED Phase PHASE2
NCT03486899 A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis Status COMPLETED Phase PHASE2
NCT03449446 Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT03445208 A Study of Experimental Medication BMS-986036 Given to Healthy Participants Status COMPLETED Phase PHASE1
NCT03439254 Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE3
NCT03332940 Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH Status TERMINATED Phase PHASE1
NCT03329885 A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis Status TERMINATED Phase PHASE1/PHASE2
NCT03282305 Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese Status NOT_YET_RECRUITING Phase N/A
NCT03248882 Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) Status COMPLETED Phase PHASE2
NCT03163810 A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH) Status WITHDRAWN Phase NA
NCT03068078 A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes Status COMPLETED Phase NA
NCT03061721 Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT03059446 Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis Status TERMINATED Phase PHASE2